78 results about "Peptidoglycan" patented technology

The invention provides engineering lyase Art-15 with broad-spectrum antibacterial activity, antibacterial peptide NZ2114 and bacteriophage lyase PlySs2 are subjected to functional fusion through an optimally designed flexible linker, and an efficient bactericidal effect on Staphylococcus aureus (Staphylococcus aureus) and Streptococcus spp.) is achieved. The engineering lyase Art-15 has the advantages that the engineering lyase Art-15 has broad-spectrum antibacterial activity, the antibacterial peptide NZ2114 and the bacteriophage lyase PlySs2 are subjected to functional fusion through the optimally designed flexible linker, and the engineering lyase Art-15 has broad-spectrum antibacterial activity; the lyase Art-15 overcomes the defects of narrow host spectrum and insufficient splitting activity of the lyase through a synergistic destruction mechanism of targeting bacterial cell wall peptidoglycan. Experiments show that the minimal inhibitory concentration (MIC) of the lyase Art-15 on staphylococcus aureus in vitro is lower than 2 mu g / mL, the minimal inhibitory concentration of the lyase Art-15 on streptococcus agalactiae is lower than 1 mu g / mL, the minimal inhibitory concentration of the lyase Art-15 on streptococcus dysgalactiae is lower than 2 mu g / mL, and the sterilization rate of the lyase Art-15 can reach 97% or above within 30 minutes by 2 times of MIC. The lyase Art-15 disclosed by the invention has important application value in the fields of drug-resistant bacterium infection treatment, medical instrument disinfection and livestock breeding.

The invention discloses a composite antibacterial preparation containing antibacterial peptide and traditional Chinese medicines as well as a preparation method and application of the composite antibacterial preparation, and belongs to the technical field of biological medicines. The antibacterial peptide provided by the invention is a transmembrane protein derived from bacteriophage, and the core function of the antibacterial peptide is that bacterial cell lysis is promoted by destroying a connection structure of a peptidoglycan layer and lipoprotein of a bacterial cell wall, so that an antibacterial effect is achieved. The amino acid sequence of the antibacterial peptide is shown as SEQ ID NO: 3, the antibacterial peptide is combined with traditional Chinese medicines to form a composite antibacterial preparation, and experiments prove that the composite antibacterial preparation has a relatively good antibacterial effect on gram-positive bacteria and gram-negative bacteria and can be applied to the medical field, such as surgical instrument disinfection and drug-resistant bacterial infection treatment; the field of daily chemicals, such as antibacterial hand sanitizers and wound dressings; in the field of agriculture, for example, animal feed additives for preventing and treating intestinal infection have a good market application prospect.

The invention discloses a bacteriostatic composition and an application thereof in a hand sanitizer, the bacteriostatic composition comprises the following components by mass: 3-5% of lysozyme, 4-8% of an enzyme protection system, 8-12% of a plant bacteriostatic extract, 10-15% of a biological matrix carrier, 5-8% of a stable protection system, and the balance of water. According to the antibacterial composition, a three-dimensional network structure is formed through the carboxymethyl chitosan-sodium alginate compound, a protective layer with good biocompatibility can be formed on the skin surface, and the skin retention time of lysozyme and plant antibacterial active ingredients is remarkably prolonged. According to the invention, lysozyme and plant antibacterial components are adopted to form multiple antibacterial mechanisms: the lysozyme specifically hydrolyzes peptidoglycan in bacterial cell walls, and active components in the plant antibacterial extract destroy bacterial cell membranes and inhibit bacterial metabolism. The double-attack mechanism has a stronger antibacterial effect than a single component, and can prevent bacteria from generating drug resistance at the same time.

The invention relates to a compound of formula Ia and / or formula Ib: or a pharmaceutically acceptable salt, solvate or prodrug thereof, where the groups are defined herein. The invention also relates to a pharmaceutical formulation comprising the compound for treating or detecting a microbial infection in a subject, a method of determining antimicrobial resistance of a microbial infection using the compound, and a method of determining an effective dose of one or more antimicrobial agents to kill a microorganism using the compound.

The invention provides a preparation method of a novel PEDV (porcine epidemic diarrhea virus) subunit vaccine, and belongs to the technical field of biology. The novel PEDV subunit vaccine is prepared by adopting a method comprising the following steps: (1) treating lactococcus lactis by using a high-pressure damp-heat method to obtain peptidoglycan particles; (2) treating the peptidoglycan particles by adopting an ultrahigh-pressure microjet technology to obtain a peptidoglycan carrier with the particle size of 280-850nm; and (3) mixing the peptidoglycan carrier with a PEDV subunit antigen of which the amino acid sequence is SEQ ID NO: 1 to obtain the novel PEDV subunit vaccine. The novel PEDV subunit vaccine comprises a peptidoglycan carrier with a specific size, can improve the in-vivo presentation efficiency of an antigen and rapidly induce efficient body fluid and mucous membrane immune response, and is of great significance to research and development of vaccines for porcine epidemic diarrhea diseases and the like.

The invention relates to the technical field of non-woven fabric preparation, in particular to biochemical modified antibacterial non-woven fabric and a preparation method thereof.After nano-zinc oxide and nano-titanium dioxide are modified through a silane coupling agent KH-570, the dispersity of nano-particles can be improved, and the antibacterial property of the non-woven fabric is improved; under illumination or contact conditions, active oxygen is released to destroy bacterial cell membranes and inhibit metabolism of the bacterial cell membranes, so that the antibacterial modified polypropylene master batch has stable antibacterial property; loading is stabilized through a polydopamine coating, so that the antibacterial performance of the lysozyme is stabilized, the lysozyme can specifically hydrolyze a peptidoglycan layer of a bacterial cell wall to cause bacterial lysis, thiourea dioxide serving as a reducing agent can maintain the activity of the lysozyme, oxidative inactivation is avoided, meanwhile, the activity of bacterial metabolic enzymes is inhibited, and the antibacterial activity of the lysozyme is improved. Through the inorganic / biological double-effect synergistic effect, gram-positive bacteria, gram-negative bacteria and fungi can be covered, so that the antibacterial performance of the non-woven fabric is improved to a certain extent.

The present disclosure provides methods, compositions, and kits for the rapid release, labeling, and detection of O-glycans present on a glycoconjugate, such as a glycoprotein, glycopeptide, peptidoglycan, or proteoglycan of interest. The compositions and methods allow the released O-glycans to be subjected to high-throughput analysis.

The invention discloses a biological preparation suitable for young pigeon growth and a preparation method and application thereof, and belongs to the technical field of feeds, the biological preparation comprises the following components by weight: 8-40 parts of a microbial agent, 1-10 parts of an additive, 1-10 parts of an antioxidant, 0.5-5 parts of peptidoglycan, and 40-60 parts of montmorillonite; the microbial agent comprises bifidobacterium animalis, lactobacillus acidophilus, lactobacillus paracasei and lactobacillus reuteri; the additive comprises at least one of yeast beta-glucan and astragalus polysaccharide. According to the biological preparation suitable for young pigeon growth, montmorillonite is used as a base material, under the combined action of the microbial inoculum, the additive, the antioxidant and peptidoglycan, the biological preparation capable of adjusting intestinal health of breeding pigeons and improving the immunity of the breeding pigeons is obtained, meanwhile, immune factors in pigeon milk can be improved, and the growth of young pigeons is promoted. The effects of improving the growth performance of the young pigeons and reducing the elimination rate of the breeding pigeons and the young pigeons can be achieved, so that economic benefits are improved, and wide application prospects are achieved.

The invention relates to the technical field of biochemistry, and discloses a hydrolase for splitting bacterial peptidoglycan causing chronic inflammatory diseases, the hydrolase is separated from a human intestinal microbe genome, and the hydrolase can hydrolyze a peptidoglycan layer of gram-positive pathogenic bacteria in a targeted manner, so that the bacterial peptidoglycan has the advantages that the bacterial peptidoglycan has a good anti-inflammatory effect, and the bacterial peptidoglycan has a good anti-inflammatory effect. The compound has high efficiency, specificity and low drug resistance and has a synergistic effect with existing antibiotics; the preparation method of the hydrolase comprises the following steps: according to an amino acid sequence, selecting escherichia coli preferred codons, and artificially synthesizing a gene sequence for coding the hydrolase; cloning the synthetic gene into an expression vector to construct a recombinant expression plasmid; transforming the recombinant expression plasmid into escherichia coli, and carrying out induced expression; the hydrolase is obtained through a separation and purification step. According to the hydrolase for splitting the bacterial peptidoglycan causing the chronic inflammatory disease, a peptidoglycan layer of gram-positive bacteria can be efficiently hydrolyzed through the hydrolase, so that the bacteria are rapidly split, and the antibacterial effect is improved.

Provided herein is a protein from Tumebacillus sp. NITE BP-02779 having a peptidoglycan-decomposing activity. Provided herein is a protein comprising the amino acid sequence of SEQ ID NO: 2 (1-164) or the amino acid sequence of SEQ ID NO: 4 (1-493), or a protein comprising an amino acid sequence in which 1 to 10 amino acid residues of these amino acid sequences are substituted, deleted, inserted, or added, or an amino acid sequence having 90% or more identity to these amino acid sequences, and having a peptidoglycan-decomposing activity.

The application discloses a chimeric endolysin Lys009-Lys009CBD and engineering and application thereof, and belongs to the field of genetic engineering and protein engineering. The application constructs a chimeric endolysin Lys009-Lys009CBD with high activity, and the peptidoglycan hydrolysis activity of the chimeric endolysin Lys009-Lys009CBD on Pseudomonas aeruginosa is 5.30 times that of natural endolysin Lys009 and 27.98 times that of hen egg white lysozyme HEWL. A transmembrane peptide P81417 is further fused to perform transmembrane modification, and an engineering endolysin P81417-Lys009-Lys009CBD is obtained. The engineering endolysin can efficiently lyse Pseudomonas aeruginosa, Acinetobacter baumannii and the like, and has excellent thermal stability. The application enriches the resource library of high-activity endolysins, provides important experimental basis and technical support for developing an anti-drug-resistant bacteria treatment strategy, and also provides a new selection for clinical treatment of multiple drug-resistant bacteria infection.

The invention provides a Babylonia areolata larva disease-resistant cultivation method based on immunostimulation, and aims to solve the problems of frequent larva diseases and low survival rate in intensive cultivation. The method comprises the following steps: selecting Babylonia areolata of Thailand and Hainan populations for reciprocal cross to obtain hybrid filial generations; in the larva stage, a compound immunologic stimulant compounded by astragalus polysaccharide, peptidoglycan and beta-glucan is adopted, the concentration is accurately regulated and controlled according to the early, middle and late stages of the daughter larvae and the creeping stage, and alternate induction is conducted through water splashing and bait mixing and feeding; when the larva shell length is 30-50mm, vibrio harveyi sublethal infection is used for enhancing immune memory, and environmental parameters such as water temperature and salinity are synchronously regulated and controlled. Tests show that the method can significantly improve the growth performance, immune enzyme activity and disease resistance of larvae, the survival rate of cultivation reaches 95% or above, the natural morbidity is lower than 6%, and technical support is provided for large-scale healthy cultivation of Babylonia areolata.

The invention belongs to the field of aquatic bacteria detection, and relates to a fluorescent array sensor as well as a preparation method and application thereof. The fluorescent array sensor comprises a plurality of DNA aptamers, the DNA aptamers respectively target lipopolysaccharide, peptidoglycan and flagellin, the DNA aptamers of the target lipopolysaccharide are EA5 and LA27, the DNA aptamer of the target peptidoglycan is Antibac2, and the DNA aptamer of the target flagellin is Aptamer 3; the sequence of the EA5 is shown as SEQ ID NO.1, the sequence of the LA27 is shown as SEQ ID NO.2, the sequence of the Antibac2 is shown as SEQ ID NO.3, and the sequence of the Aptamer 3 is shown as SEQ ID NO.4. The invention further discloses a kit for detecting the content of the EA5, the LA27, the Antibac2 and the Aptamer. According to the present invention, the six bacteria can be simultaneously detected, the detection limit is low, the operation process is simple, and the detection accuracy can achieve 97.6%.

The invention discloses a mattress material based on modified fibers and a preparation method of the mattress material. The mattress material comprises nylon 66 fibers, low-melting-point fibers and the modified fibers. The low-melting-point fiber is ES bi-component parallel composite fiber composed of polypropylene and polyethylene, and the modified fiber is prepared by mixing a modified polymer and a modified filler to prepare a spinning solution and then carrying out electrostatic spinning and ultraviolet irradiation. Molecular chains of the modified polymer contain rich furan rings and thiophene rings, synthesis of bacterial cell walls can be destroyed, the furan is grafted with oximido, and a formed furan oxime ester unit can generate highly unstable and reactive free radicals, so that metal ions in cells are unbalanced to cause change of cell metabolism homeostasis. The lysozyme fixed on the modified filler can be hydrolyzed to form peptidoglycan of bacterial cell walls, so that the cell walls are broken, and the material has good antibacterial performance.

The invention relates to the technical field of biological adsorption materials, in particular to modified peptidoglycan with an efficient adsorption effect and a preparation method and application of the modified peptidoglycan. The preparation method comprises the steps of grafting and modifying carboxyl / hydroxyl of peptidoglycan, so that multi-site and multi-mode functional modification on the surface of the peptidoglycan is realized. The physicochemical properties of functional groups on the surface of peptidoglycan are changed through modification treatment, the density and electronegativity of carboxyl and hydroxyl functional groups on the surface of peptidoglycan are improved, the hydrogen-bond interaction and electrostatic adsorption capacity between the peptidoglycan and biotoxin are enhanced, and the adsorption efficiency is improved. In addition, the peptidoglycan is subjected to carboxyl and hydroxyl modification at the same time, and the tetrodotoxin adsorption effect of the peptidoglycan can be further improved. The technology provides a new strategy for functionalization of natural polymer materials, has good theoretical popularization value and application prospects, and is suitable for the fields of food safety, removal and purification of biotoxins and the like.

The invention relates to the first hydrolase that specifically digests the archaeal type of a peptidoglycan (PG), the major component of the cell wall of methanogens, named Talosaminidase. The enzyme consists of a signal peptide, several bacterial IG domains, a glycosyl hydrolase, several archaeal PG binding domains and a peptidase domain. The double enzymatic activity for the glycosyl hydrolase and the peptidase maximizes the lysis of archaeal cells with a cell wall of the archaeal PG-type. Engineering the enzyme by removing the signal peptide and bacterial IG domains and keeping only the archaeal PG binding, glycosyl hydrolase and peptidase made the enzyme easier to express and purify, without negatively influencing the enzymatic activity. Therefore, engineered Talosaminidase can be used to regulate populations of archaeal methanogens in the industrial, agricultural and medical settings, and consequently methane production.

The invention provides a postbiotic immunomodulatory preparation based on bifidobacterium longum CD11 and a preparation method of the postbiotic immunomodulatory preparation. Bifidobacterium longum CD11 is used to prepare a metagen. The immunocompetence of RAW264.7 macrophages can be promoted by thermal inactivation of bifidobacterium longum CD11 metabolites, cell walls, cell membranes and cell content metabolite components, and the cell wall component dose-dependently promotes the proliferation of the RAW264.7 macrophages and inhibits the relative expression of mRNA genes of inflammatory factors TNF-alpha and IL-1beta. In addition, a peptidoglycan (PGN) metagen from a cell wall component can remarkably inhibit relative expression of TNF-alpha and IL-1beta mRNA genes of RAW264.7 macrophages, so that inflammation is recovered to a health level (NC group level). Therefore, the bifidobacterium longum CD11 can be used as a potential immunomodulatory metabiotic strain.

The invention is directed to immunological compositions of one or more peptides containing epitopes of PGN, LTA and LPS molecules that induce an immunological response in a mammal, and to multiple antibodies that bind to these epitopes. Immunological compositions and antibodies disclosed herein can be used in the treatment and / or prevention of human health disorders such as bacterial sepsis, inflammation, cancers, tumors, inflammatory diseases and disorders, and neurodegenerative disorders such as, but not limited to Alzheimer's disease, frontotemporal dementia, chronic traumatic encephalopathy (CTE), Lewy body dementia and / or limbic predominant age-related TDP-43 encephalopathy (LATE).

The invention belongs to the field of food safety, and discloses application of cell wall lyase LysM15 in preparation of a bacillus cereus inhibitor. The cell wall lyase LysM15 has the functions of specifically recognizing the cell wall of the bacillus cereus and efficiently cracking the peptidoglycan layer of the bacillus cereus. The LysM15 not only can obviously inhibit the germination of bacillus cereus spores and remove biofilms of the bacillus cereus spores, but also can keep higher enzyme activity in a temperature range of 4-50 DEG C and in a high-salt environment. The lyase has good biocompatibility, growth and pollution of bacillus cereus in fresh beef can be effectively reduced, the potential of the lyase serving as a food preservative is shown, and a safe and efficient solution can be provided for food preservation.

The invention belongs to the technical field of molecular biology, and relates to a truncated fish peptidoglycan recognition protein and application thereof. The amino acid sequence of the truncated fish peptidoglycan recognition protein is as shown in SEQ ID NO. 1 in the table. Compared with a natural peptidoglycan recognition protein, the truncated fish peptidoglycan recognition protein provided by the invention has higher expression efficiency and higher yield in a prokaryotic expression system; in addition, the binding capacity with main components, namely peptidoglycan (PGN) and lipopolysaccharide (LPS), of cell walls of gram-positive bacteria and gram-negative bacteria is higher; the bacteriostasis and agglutination capacities on gram-positive bacteria and gram-negative bacteria are obviously improved. The characteristics show that the truncated fish peptidoglycan recognition protein has the development potential as an aquatic product immunopotentiator, and important support is provided for subsequent application research.

The invention discloses a sperm-friendly medical lubricant and a preparation method thereof. The lubricant comprises the following components: a water-based matrix, an active component, phosphate, a humectant, an osmotic pressure regulator and water, the active ingredients comprise small molecule peptidoglycan and alkaline polypeptide. The alkaline polypeptide is alkaline protein, can mildly improve the pH environment of the vagina and is beneficial to maintaining the activity of sperms, and the small molecule peptidoglycan has a good adhesion effect on vaginal epithelial cells, can be adhered to the vaginal epithelial cells and prevents the alkaline polypeptide from stimulating the vaginal inner wall; the small molecule peptidoglycan also can promote local immune regulation, enhance secretion of anti-inflammatory factors and immune response of macrophages, and improve the anti-infection ability of vagina; the composition of the two active substances can maintain sperm activity and protect and resist infection on the vagina at the same time, and is a lubricant which is friendly to the vagina and sperms.

Described herein are assays, techniques, methods, and compositions capable of detecting a Borrelia burgdorferi microorganism, the causative agent of Lyme's disease.

The invention provides a primer pair, a kit and a method for detecting tilium pneumoniae, the primer pair comprises a forward primer and a reverse primer aiming at a peptidoglycan related lipoprotein (Pal) gene, and the Pal gene comprises a nucleotide sequence as shown in SEQ ID NO: 15. The length of the forward primer is 15-25 nucleotides, and the forward primer corresponds to a nucleotide sequence between the first site and the 33 site shown in SEQ ID NO: 15. The length of the retrograde primer is 15 to 30 nucleotides, and the retrograde primer corresponds to a nucleotide sequence between the 64th site and the 123 site of SEQ ID NO: 15. The invention also provides a kit containing the primer pair and used for detecting the lepidomonas pneumoniae, and a method for detecting the lepidomonas pneumoniae by using the primer pair.

The present invention belongs to the technical field of food additives, and specifically relates to a method for preparing a natural plant pigment composition and its use in food. The preparation method comprises the following steps: S1: dissolving a natural plant pigment in water to obtain a natural plant pigment solution, adjusting the pH of the natural plant pigment solution to 7-8, then adding cyclodextrin and stirring evenly, continuously stirring, and allowing the solution to stand after stirring to obtain solution I; S2: adding spirulina peptidoglycan and polyamino acid to the obtained solution I in sequence, mixing evenly, stirring, adding a halide salt after stirring, continuing stirring, allowing the solution to stand after stirring, and then centrifuging. The resulting solid product is mixed with edible supplements and freeze-dried to obtain the natural plant pigment composition. The raw materials used in the present invention are all food-grade, safe and harmless, and can be used in food dyeing and coloring, imparting saturated and uniform color to food and beverage products, and enhancing the vividness of food.

The present invention belongs to the technical field of organic synthesis, and particularly relates to a method for one-pot relay glycosylation to synthesize 1,3-dithiosaccharides. The present invention first realizes "one-pot relay glycosylation": directly converting glycosyl thiol, 3-O-acetyl-2-nitro sugar olefin and another thiol acceptor into 1,3-dithio-2-nitro iduronic glycoside. This method has the advantages of good regioselectivity and stereoselectivity, mild reaction conditions, simple operation, good substrate generality and high synthesis efficiency. The present invention also realizes "one-pot relay glycosylation": directly converting glycosyl thiol, 3-O-acetyl-2-nitro glucose olefin and another thiol acceptor into 1,3-dithio-2-nitro mannoside / glucoside. The present invention also uses "one-pot relay glycosylation" to efficiently and stereoselectively synthesize peptidoglycans with 1,3-linkage, 1,4-linkage and 1,6-linkage, providing a new way for the effective synthesis of peptidoglycan fragment analog thio compounds, and having important application prospects.

A uridine diphosphate-N-difluoroacetylglucosamine, a preparation method therefor and a use thereof. The uridine diphosphate-N-difluoroacetylglucosamine has a similar chemical structure to the natural substrate UDP-GlcNAc, the difference being that the 2-position N-acetyl group thereof is replaced by an N-difluoroacetyl group. The preparation method is as follows: (1) preparing difluoroacetylglucosamine; (2) using difluoroacetylglucosamine as a substrate to prepare uridine diphosphate-N-difluoroacetylglucosamine. A novel, highly active, non-hydrolyzable and artificially synthesizable artificial donor sugar uridine diphosphate-N-difluoroacetylglucosamine (UDP-GlcNDFA) is provided. Compared with the existing donor sugar UDP-GlcNTFA, UDP-GlcNDFA has higher catalytic activity for glycosyltransferases, is stable and not easily hydrolyzed, and can be used as a donor substrate for chemoenzymatic synthesis of heparin oligosaccharide scaffolds, heparin oligosaccharide intermediates and heparin oligosaccharides, as well as hyaluronic acid oligosaccharides, glycoconjugates (glycosylated polypeptides) and polysaccharide antigens.

This invention relates to the field of nonwoven fabric preparation technology, specifically to a biochemically modified antibacterial nonwoven fabric and its preparation method. This invention modifies nano-zinc oxide and nano-titanium dioxide using the silane coupling agent KH-570, improving the dispersibility of the nanoparticles. Under light or contact conditions, the nanoparticles release reactive oxygen species to disrupt bacterial cell membranes and inhibit their metabolism, thereby giving the antibacterial modified polypropylene masterbatch stable antibacterial properties. Furthermore, this invention stabilizes the loading through a polydopamine coating, thus stabilizing the antibacterial properties of lysozyme. Lysozyme specifically hydrolyzes the peptidoglycan layer of bacterial cell walls, leading to bacterial lysis. Thiourea dioxide, as a reducing agent, maintains lysozyme activity, preventing oxidative inactivation, while simultaneously inhibiting bacterial metabolic enzyme activity. Through the synergistic effect of inorganic and biological dual-effects, this invention can cover Gram-positive bacteria, Gram-negative bacteria, and fungi, thereby improving the antibacterial properties of the nonwoven fabric to a certain extent.

This invention relates to the field of microbial technology and discloses a lactic acid bacteria postbiotic containing γ-aminobutyric acid (GABA) and its preparation method. It aims to solve the problems of GABA loss, damage to the active structure of the postbiotic cells, and insufficient synergistic utilization of GABA and GABA-containing lactic acid bacteria postbiotics during heat inactivation and drying processes. The method involves fermenting GABA-producing lactic acid bacteria, centrifuging to collect the supernatant and bacterial cells, desalting, removing impurities, and concentrating the supernatant to obtain a GABA-rich solution. The bacterial cell precipitate is washed, resuspended in a buffer solution containing calcium ions and trehalose, and allowed to stand. It is then adjusted to an acidic state to induce peptidoglycan conformation protection, followed by staged heat inactivation. After being combined with the GABA-rich solution and a composite protectant, it is dried at low temperature to obtain the GABA-containing lactic acid bacteria postbiotic. This provides a reliable technical solution for preparing highly active GABA-containing postbiotic products.

The invention discloses a condom added with sophocarpidine hyaluronic acid lubricating liquid and a preparation method of the condom, and belongs to the technical field of condom production. The core of the method is that after matrine is dissolved, the matrine is added into hyaluronic acid lubricating liquid for the condoms, the hyaluronic acid lubricating liquid containing the matrine is prepared through stirring and mixing, the concentration of the matrine in the hyaluronic acid lubricating liquid is 7.7-25.0 mg / g, when the condoms are subjected to inner packaging, the matrine-containing lubricating agent is added into the condoms, and when the condoms are subjected to inner packaging, the matrine-containing lubricating agent is added into the condoms. And preparing the condom added with the sophocarpidine-containing hyaluronic acid lubricating liquid. According to the condom, inflammation generated after vaginal epithelial cells are stimulated by bacterial structural components is improved through matrine, and the common pathogenic bacteria such as staphylococcus aureus, escherichia coli, enterococcus faecalis and streptococcus agalactiae of vaginitis are inhibited in the using process; and the up-regulation level of NF-kB phosphorylation generated after lipopolysaccharide and peptidoglycan stimulate vaginal epithelial cells is relieved.

The present invention provides a probiotic composition for inhibiting Helicobacter pylori. Lacticaseibacillus rhamnosus was preserved in Guangdong Microbial Culture Collection Center on 11 April 2024, and the accession number is GDMCC NO: 64513. Lactiplantibacillusplantarum was preserved in Guangdong Microbial Culture Collection Center on 11 April 2024, and the accession number is GDMCC NO: 64514. The advantage is: peptidoglycans extracted from the Lacticaseibacillus rhamnosus and the Lactiplantibacillusplantarum can effectively inhibit Helicobacter pylori. The combination of peptidoglycans from the two strains exhibits an enhanced ability to inhibit Helicobacter pylori compared with the same concentration of peptidoglycan from a single strain.